Navigation Links
Biomarkers Market: Epigenetic & MicroRNA Biomarkers Report

DALLAS, Aug. 16, 2013 /PRNewswire-iReach/ -- The epigenetic and microRNA biomarkers fields are co-evolving and have reached a critical point wherein enough signatures have been identified across various different disease classes, most notably in cancer, that some of these signatures/expression patterns can be validated and deployed for use in the clinic.  However, these biomarker fields are evolving in parallel with the research marketplace, and this market report characterizes the research markets for both these fields so as to present a comprehensive analysis that en bloc provides a complete picture of this expanding marketplace.


The Epigenetic and MicroRNA Biomarkers 2013 Market Report

( ) is written in PowerPoint and is delivered to customers in this format enabling convenient drag-and-drop into R&D Presentations, Business Plans, Investor Presentations.  Associated files that constitute the complete report package are in Excel and PDF formats.

Specific Topics Addressed in this Market Report:

  • Epigenetics Research Market Analysis
    • Primary Market Survey to Characterize Research Market Trends based on Data Collected from Researchers
    • Breakout of Epigenetics Research Activity based on Epigenetic Modifications Studied
    • Segmentation of Epigenetics Research Activity based on Disease Classes Studied
    • Epigenetics Research Activity in Cancer--Quantitative Segmentation
    • Reagent Kits and Products in the Epigenetics Research Field [Details of Products from the Vendors in this Space are Presented and Analyzed]
  • Epigenetics Biomarkers
  • En masse Analysis of All Epigenetics-focused Publications and Trends from these Data with respect to Potential Epigenetics Biomarkers
  • Description of Epigenetic Biomarkers Identified to Date in Various Cancer Classes [Nature of Epigenetic Signature, Potential Role in Prognostics and Diagnostics]
  • Primary Market Survey Data Presents a Complete Picture of the microRNA Research Field based on End-User/Researcher Practices
  • Methodologies and Market Breakout for Expression Profiling
  • Quantitative Breakout of the microRNA Research Market Across the Research Workflow
  • Product Vendors and their Quantitative Penetrance in the microRNA Research Markets
  • Expression Patterns/Signatures of microRNAs in Different Disease States
  • Prognostic/Diagnostic Potential of microRNA Expression Patterns
  • microRNAs in Biological Fluids as Circulating Biomarkers: List and Significance
  • Traditional Cancer Biomarkers
  • Oncogenes
  • Tumor-Suppressor Genes
  • Up-to-date List of CDx on the Marketplace
  • Partnerships in the CDx Space
  • MicroRNA Research Market Analysis
  • MicroRNA Biomarkers Analysis
  • Cancer Biomarker Classes
  • Companion Diagnostics (CDx)

Buy a copy of this report at .

Table of Contents for the Epigenetic and MicroRNA Biomarkers 2013 Market Report:

Chapter I. Epigenetics Research Market Analysis
Primary market survey to Characterize Marketplace from the
Bottom-up: Qualitative and Qualitative Market Data
Current Research Paradigms
Quantitative Segmentation of Epigenetics Research
Epigenetics research in Cancer: Quantitative Segmentation
Commercial kit and Reagent offering in the Epigenetics Research Marketplace

Chapter II. Epigenetic Signature as Potential Biomarkers
Big Data Analysis of Epigenetics Publication Landscapes
Hotspot Analysis of Publications Describes Segments of Opportunity vis-a-vis Research Product Development as well Potential Assay Development for Disease Associations, Harvesting of Prognostic as well as Diagnostic Biomarkers
Epigenetic Signatures Described in Various Disease Classes
DNA Methylation as Disease Biomarkers
Histone Modification as Disease Biomarkers
Potential Epigenetic Biomarkers in Various Cancer Classes
Gastric Cancer
Pancreatic Cancer
Prostate Cancer

Chapter III. micrRNA Research Market Analysis microRNA Signatures as Potential Biomarkers
Primary Market Survey to Characterize Marketplace from the Bottom-Up: Quantitative and Quantitative Market Data
microRNA Research vis-à-vis Content Classes
microRNA Research in Cancer
microRNA Research Workflow: Quantitative Breakout
microRNA Expression Profiling Quantitative market breakout
microRNA Vendor Market Penetration Space Map
NGS to study micrRNAs-Market Breakout by Platform
Unmet Needs in the microRNA Research Space
microRNA Signatures Describes in Various Disease Classes: Potential for Biomarkers Development
Tumor Suppressor microRNA Methylatoin
microRNA in Biofluids
Circulating microRNAs as Potential Tumor Markers

Chapter IV. Characterization of Molecular Biomarker Classes
Traditional Cancer Biomarkers
Tumor Suppressor Genes

Appendix I. Epigenetics and MicroRNA Biomarkers Summary

Appendix II. List of Companion Diagnostics (Cdx) on the Market, In Progress Cdx in Development/Partnership, Potential Market Size for Epigenetics and microRNA-based CDx

Appendix III. Research Methodology

Complete report available at .

You may also be interested in other reports we have biomarkers:

PharmaFocus: Biomarkers in Alzheimer's Disease at .

Biomarker Partnering Terms and Agreements at .

Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) – Forecasts from 2012 to 2017 at .

Explore all reports on biomarkers market at .

About Us: is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. Call +1 888 391 5441 with your research requirements.

Media Contact: Priyank Tiwari,, +1 888 391 5441,

News distributed by PR Newswire iReach:

Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. HUNT Biosciences and SomaLogic collaborate to validate protein biomarkers of cardiovascular risk
2. Trial seeks improved lung-cancer screening by combining imaging and biomarkers
3. Air pollution level changes in Beijing linked with biomarkers of cardiovascular disease
4. VTT and GE Healthcare developing novel biomarkers to predict Alzheimers disease
5. VEGF Inhibition: Therapy-Indicating and Prognostic Biomarkers, 2013
6. Spanish researchers design biomarkers for the detection of dengue and West Nile virus
7. NIH funds research to identify Parkinsons biomarkers
8. New AAN/ALS Association Clinical Fellow Will Pursue Immune Biomarkers
9. Epigenetic biomarkers may predict if a specific diet and exercise regimen will work
10. Novel biomarkers improve diagnosis in rheumatoid arthritis
11. hESC Products Market: Human Embryonic Stem Cell Patent IP Landscape Opportunity Analysis in New Research Report
Post Your Comments:
(Date:10/29/2015)... Mich. , Oct. 29, 2015  Rubicon ... Genomics for U.S. distribution of its DNA library ... kit and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX ... enable the preparation of NGS libraries for liquid ... for diagnostic and prognostic applications in cancer and ...
(Date:10/27/2015)... 27, 2015 In the present market scenario, ... for various industry verticals such as banking, healthcare, defense, ... growing demand for secure & simplified access control and ... as hacking of bank accounts, misuse of users, , ... as PC,s, laptops, and smartphones are expected to provide ...
(Date:10/26/2015)... PALO ALTO, Calif. and LAS ... – Nok Nok Labs , an innovator in ... FIDO Alliance , today announced the launch of its ... the first unified platform enabling organizations to use standards-based ... authentication. The Nok Nok S3 Authentication Suite is ideal ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... IIROC on behalf of the Toronto Stock Exchange, confirms ... there are no corporate developments that would cause the ... --> --> About Aeterna Zentaris ... . --> Aeterna Zentaris is a specialty ...
(Date:11/24/2015)... , ... November 24, 2015 , ... The Academy of ... Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to represent the First–Person ... few years. Many AMA members have embraced this type of racing and several new ...
(Date:11/24/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) ... remaining 11,000 post-share consolidation (or 1,100,000 pre-share consolidation) ... B Warrants") subject to the previously disclosed November ... 2015, which will result in the issuance of ... the issuance of such shares, there will be ...
(Date:11/24/2015)... ... November 24, 2015 , ... Creation Technologies ... being named to Deloitte's 2015 Technology Fast 500 list of the fastest growing ... a FDA-cleared, Class II medical device that speeds up orthodontic tooth movement by ...
Breaking Biology Technology: